Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058338) titled 'Genomic screening study in patients with newly-diagnosed untreated acute myeloid leukemia' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center
Condition:
Condition - Acute myeloid leukemia
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To identify patients with high-risk AML according to new criteria defined by genetic mutations and to determine the response factors (including genetic information) to standard chemotherapy, including Vyxeos(R), for these patients. In addition, we will verify whether the Amoy DX(R) Myeloid B...